A comparison of the effects of quetiapine and olanzapine on glucose metabolism in patients with schizophrenia

被引：0
|
作者：
Henderson, D [1 ]
Copeland, PM [1 ]
Borba, CP [1 ]
Nguyen, DD [1 ]
Evins, AE [1 ]
Zhang, H [1 ]
Hayden, D [1 ]
Freudenreich, O [1 ]
Cather, C [1 ]
Schoenfeld, D [1 ]
Goff, DC [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S494 / S495
页数：2
相关论文
共 50 条
  • [21] Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia
    Lobacheva, O.
    Nikitina, V.
    Kornetova, E.
    Vladimirova, S.
    Semke, A.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S765 - S765
  • [22] A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone
    Newcomer, John W.
    Ratner, Robert E.
    Eriksson, Jan W.
    Emsley, Robin
    Meulien, Didier
    Miller, Frank
    Leonova-Edlund, Julia
    Leong, Ronald W.
    Brecher, Martin
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 487 - 499
  • [23] Quetiapine improves symptoms and is well tolerated in patients with schizophrenia switched from olanzapine
    Larmo, I
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S313 - S314
  • [24] Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia
    Michael Riedel
    Norbert Müller
    Ilja Spellmann
    Rolf R. Engel
    Richard Musil
    Rosamaria Valdevit
    Sandra Dehning
    Anette Douhet
    Anja Cerovecki
    Martin Strassnig
    Hans-Jürgen Möller
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 402 - 412
  • [25] Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia
    Riedel, Michael
    Mueller, Norbert
    Spellmann, Ilja
    Engel, Rolf R.
    Musil, Richard
    Valdevit, Rosamaria
    Dehning, Sandra
    Douhet, Anette
    Cerovecki, Anja
    Strassnig, Martin
    Moeller, Hans-Juergen
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (07) : 402 - 412
  • [26] Comparison of the effects of quetiapine and haloperidol in a cohort of patients with treatment-resistant schizophrenia
    Buckley, PF
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 221 - 221
  • [27] Comparison of the neurocognitive effects of quetiapine and haloperidol in patients with schizophrenia: A functional MRI study
    Ibrahim, Hisharn
    Preda, Adrian
    Jain, Satyarn
    Burns, Wilma
    Cheng, Peingfei
    Greene, Robert W.
    Tamminga, Carol
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 242S - 242S
  • [28] Comparison of risperidone, olanzapine and quetiapine for body weight, serum blood glucose and prolactin levels
    Chaudhry, H.
    Arshad, N.
    Niaz, S.
    Suleman, T.
    Mufti, K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S511 - S512
  • [29] Effectiveness of haloperidol, olanzapine and quetiapine in reducing aggressive behaviour in forensic in-patients with schizophrenia
    Mosescu, M.
    Bragau, M.
    Popescu, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S490 - S490
  • [30] Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone
    Larmo, I
    de Nayer, A
    Windhager, E
    Irmansyah
    Lindenbauer, B
    Rittmannsberger, H
    Platz, T
    Jones, AM
    Altman, C
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (08) : 573 - 581
12345